Measles Diagnosis, Treatment, and Prevention
Introduction to Measles
- Measles is a highly contagious viral illness characterized by generalized rash, fever, cough, coryza, or conjunctivitis, as noted by the CDC 1
- Prevention through vaccination remains the most effective strategy against measles, providing lifelong immunity 1
Specimen Collection and Testing
- A single serum specimen can be obtained soon after rash onset, and if IgM is negative in the first specimen, a second specimen should be collected 5 days after rash onset, as recommended by the CDC 1
- Paired IgG antibody testing can detect a significant rise between acute and convalescent-phase serum specimens, with the acute-phase specimen collected within a short period after rash onset and the convalescent-phase specimen collected at least 10 days after the acute specimen 1
- RT-PCR detection of viral RNA should be collected as close to rash onset as possible, as delay in collection reduces the chance of virus isolation, according to the CDC 1
The World Health Organization (WHO) suggests that RT-PCR specific for genotype A (vaccine strain) can differentiate between vaccine and wild-type strains, and analysis of the difference between Ct values (delta Ct) can help identify possible co-infections:
Delta Ct Value Interpretation <2.9 Only vaccine virus >3.7 Co-infection with wild-type virus 2.9-3.7 Requires additional confirmation
Interpretation of Test Results
- False-negative IgM results may occur even with appropriately timed specimens, and false-positive IgM results may occur in patients with certain viral infections or rheumatoid factor positive patients, as noted by the CDC 1
- Measles-specific IgM antibody test can detect measles exposure as early as 1-2 days after rash onset and remains detectable for 4-12 weeks, with the most reliable results within 4-5 weeks after rash onset 1
- A significant rise in IgG antibody levels requires paired serum samples, with the acute-phase sample collected within 7 days after rash onset and the convalescent-phase sample collected at least 10 days after the acute-phase specimen, and a fourfold rise in antibody titer indicates recent infection 1
Molecular Characterization and Reporting
- Molecular characterization of measles virus isolates is important for defining epidemiologic features during low disease incidence, documenting impact of elimination efforts, but cannot be used for immediate diagnosis, as stated by the CDC 1
- All suspected measles cases should be reported immediately to local health departments, and laboratory confirmation is especially important for isolated cases not part of an outbreak, according to the CDC 1
- Control activities should not be delayed pending laboratory results, as recommended by the CDC 1
Treatment and Management
- Management of measles primarily consists of supportive care, including correction of dehydration, nutritional support, treatment of secondary bacterial infections, and vitamin A supplementation, as recommended by the WHO 1
- The CDC and Advisory Committee on Immunization Practices (ACIP) guidelines do not recommend corticosteroids like prednisolone for routine management of measles rash, as it may worsen outcomes by suppressing immune response to the viral infection 1
Prevention and Control
- Vaccination of susceptible contacts is crucial, and the CDC recommends identifying and vaccinating susceptible individuals at risk of exposure 1
- Unvaccinated individuals should be excluded from outbreak settings until 21 days after the last case, and healthcare staff caring for patients with suspected measles or congenital rubella syndrome should be immune, as recommended by the CDC 1
- The CDC recommends implementing airborne precautions for measles and contact isolation for suspected congenital rubella syndrome 1
- Suspected measles cases should be reported immediately to the local/state health department, without delaying control activities pending laboratory results 1
Special Considerations
- Co-infections may obscure typical clinical features and complicate diagnosis, and diagnostic challenges in pregnant women may require special attention, as noted by the CDC 1
- Congenital Rubella Syndrome (CRS) requires special attention as it indicates unrecognized rubella in the community, and prenatal screening is recommended by the CDC 1
- The American Academy of Pediatrics recommends considering the patient's immunocompromised status when evaluating suspected vaccine reactions, as these patients may be at higher risk of vaccine reactions even with negative RT-PCR results, especially if there is a recent history of vaccination 1